Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-15 · accession 0001209191-24-003487 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-16 | 2024-02-15 | RXRX | Marriott Tina | Pres, COO | F - Tax | $12.43 | -5,379 | 640.0K | -0.8% | -$66.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-15 | F | D | 5,379 | $12.43 | 639,982 | D | — | — |